Definium Therapeutics, Inc. (DFTX)
38.10
+1.02
(+2.75%)
USD |
NASDAQ |
Oct 28, 16:00
38.10
0.00 (0.00%)
After-Hours: 20:00
Definium Therapeutics Market Cap : 5.119B for Oct. 28, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 27, 2026 | 4.982B |
| October 26, 2026 | 4.794B |
| October 23, 2026 | 4.793B |
| October 22, 2026 | 4.837B |
| October 21, 2026 | 4.769B |
| October 20, 2026 | 4.715B |
| October 19, 2026 | 4.430B |
| October 16, 2026 | 4.313B |
| October 15, 2026 | 4.603B |
| October 14, 2026 | 4.601B |
| October 13, 2026 | 4.620B |
| October 12, 2026 | 4.730B |
| October 09, 2026 | 4.958B |
| October 08, 2026 | 4.593B |
| October 07, 2026 | 4.715B |
| October 06, 2026 | 4.786B |
| October 05, 2026 | 4.868B |
| October 02, 2026 | 5.025B |
| October 01, 2026 | 5.052B |
| September 30, 2026 | 5.114B |
| September 29, 2026 | 5.134B |
| September 28, 2026 | 5.161B |
| September 25, 2026 | 4.860B |
| September 24, 2026 | 4.935B |
| September 23, 2026 | 5.059B |
| Date | Value |
|---|---|
| September 22, 2026 | 5.418B |
| September 21, 2026 | 5.278B |
| September 18, 2026 | 5.215B |
| September 17, 2026 | 5.197B |
| September 16, 2026 | 5.086B |
| September 15, 2026 | 4.947B |
| September 14, 2026 | 5.408B |
| September 11, 2026 | 5.225B |
| September 10, 2026 | 5.070B |
| September 09, 2026 | 5.105B |
| September 08, 2026 | 5.137B |
| September 04, 2026 | 5.118B |
| September 03, 2026 | 5.106B |
| September 02, 2026 | 5.227B |
| September 01, 2026 | 5.173B |
| August 31, 2026 | 5.337B |
| August 28, 2026 | 5.506B |
| August 27, 2026 | 5.888B |
| August 26, 2026 | 5.881B |
| August 25, 2026 | 6.021B |
| August 24, 2026 | 5.814B |
| August 21, 2026 | 6.034B |
| August 20, 2026 | 6.100B |
| August 19, 2026 | 6.157B |
| August 18, 2026 | 6.205B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Enliven Therapeutics, Inc. | 3.279B |
| Cocrystal Pharma, Inc. | 13.79M |
| CNBX Pharmaceuticals, Inc. | 0.1476M |
| Arvinas, Inc. | 495.63M |
| Fulcrum Therapeutics, Inc. | 287.60M |
Market Cap Related Metrics
| PEG Ratio | -0.0821 |
| Price to Book Value | 5.572 |
| Price | 38.10 |
| Earnings Yield | -9.03% |
| PEGY Ratio | -0.0821 |